| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 33.830 | 56.653 | 84.995 | 112.010 | 94.322 | 131.833 | 151.192 | 201.892 | 226.384 |
| Total Income - EUR | - | 33.830 | 56.653 | 84.995 | 112.010 | 94.322 | 131.900 | 151.220 | 201.923 | 226.384 |
| Total Expenses - EUR | - | 4.201 | 9.426 | 8.324 | 10.051 | 23.612 | 18.414 | 46.893 | 16.201 | 16.336 |
| Gross Profit/Loss - EUR | - | 29.630 | 47.228 | 76.671 | 101.959 | 70.709 | 113.486 | 104.326 | 185.722 | 210.048 |
| Net Profit/Loss - EUR | - | 28.614 | 45.528 | 74.121 | 100.089 | 69.784 | 112.169 | 102.814 | 184.249 | 204.072 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Danielagyn Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 116 | 114 | 112 | 0 | 0 | 2.105 | 22.389 | 22.321 | 22.196 |
| Current Assets | - | 29.159 | 74.235 | 147.054 | 100.860 | 70.608 | 229.485 | 115.406 | 189.997 | 71.283 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 27.375 | 0 | 0 | 0 |
| Receivables | - | 3.545 | 8.268 | 7.425 | 8.669 | 6.311 | 193.809 | 84.277 | 187.644 | 69.320 |
| Cash | - | 25.614 | 65.968 | 139.629 | 92.191 | 64.297 | 8.300 | 31.129 | 2.353 | 1.963 |
| Shareholders Funds | - | 28.659 | 73.701 | 146.470 | 100.139 | 69.834 | 180.454 | 102.863 | 184.297 | 60.918 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 616 | 648 | 695 | 721 | 774 | 51.135 | 34.932 | 28.021 | 32.561 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Danielagyn Srl